Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer

NCT02560038 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped slow enrollment; resource re-allocation

Conditions

Urinary Bladder Neoplasms

Interventions

DRUG: Gemcitabine
DRUG: Paclitaxel
DRUG: Cisplatin

Sponsor

The University of Texas Health Science Center, Houston